| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Director | Stock Option (right to buy Common Stock) | 50K | May 2, 2025 | Direct | ||
| Pasithea Therapeutics Corp. | Director | Stock Option (right to buy) | 7.5K | Mar 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INTS | INTENSITY THERAPEUTICS, INC. | May 2, 2025 | 1 | $0 | 4 | May 6, 2025 | Director |
| INTS | INTENSITY THERAPEUTICS, INC. | Mar 6, 2024 | 1 | $0 | 4 | Mar 7, 2024 | Director |
| KTTA | Pasithea Therapeutics Corp. | Mar 1, 2024 | 1 | $0 | 4/A | Apr 5, 2024 | Director |
| KTTA | Pasithea Therapeutics Corp. | Mar 1, 2024 | 1 | $0 | 4 | Mar 1, 2024 | Director |
| INTS | INTENSITY THERAPEUTICS, INC. | Jun 29, 2023 | 0 | $0 | 3 | Jun 29, 2023 | Director |
| KTTA | Pasithea Therapeutics Corp. | Sep 14, 2021 | 0 | $0 | 3 | Sep 14, 2021 | Director |